よむ、つかう、まなぶ。
資料３－11―① 押谷先生・鈴木先生・西浦先生・脇田先生提出資料 (14 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000121431_00395.html |
| 出典情報 | 新型コロナウイルス感染症対策アドバイザリーボード (第110回 12／14)《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
15.
Faust, J. S. & del Rio, C. Assessment of Deaths From COVID-19 and From Seasonal
Influenza. JAMA Intern Med 180, 1045–1046 (2020).
16.
World Health Organization. Estimating mortality from COVID-19. Scientific Brief.
https://www.who.int/news-room/commentaries/detail/estimating-mortality-fromcovid-19 (2020).
17.
Baker, M. G. & Wilson, N. The covid-19 elimination debate needs correct data. BMJ
371, (2020).
18.
Leung, N. H. L., Xu, C., Ip, D. K. M. & Cowling, B. J. The fraction of influenza virus
infections that are asymptomatic: a systematic review and meta-analysis. Epidemiology
26, 862 (2015).
19.
Askani, E. et al. Computed Tomographic Imaging Features of COVID-19 Pneumonia
Caused by the Delta (B.1.617.2) and Omicron (B.1.1.529) Variant in a German
Nested Cohort Pilot Study Group. Tomography 2022, Vol. 8, Pages 2435-2449 8,
2435–2449 (2022).
20.
Yoon, S. H., Lee, J. H. & Kim, B.-N. Chest CT Findings in Hospitalized Patients with
SARS-CoV-2:
Delta
versus
Omicron
Variants.
https://doi.org/10.1148/radiol.220676 (2022) doi:10.1148/RADIOL.220676.
21.
Falsey, A. R. & Walsh, E. E. Viral pneumonia in older adults. Clinical Infectious
Diseases 42, 518–524 (2006).
22.
Bhattacharyya, R. P. & Hanage, W. P. Challenges in Inferring Intrinsic Severity of the
SARS-CoV-2 Omicron Variant. New England Journal of Medicine 386, e14 (2022).
23.
Guo, T. et al. Cardiovascular Implications of Fatal Outcomes of Patients with
Coronavirus Disease 2019 (COVID-19). JAMA Cardiol 5, 811–818 (2020).
24.
Zheng, Y.-Y., Ma, Y.-T., Zhang, J.-Y. & Xie, X. COVID-19 and the cardiovascular
system. Nat Rev Cardiol doi:10.1038/s41569-020-0360-5.
25.
Xie, Y., Xu, E., Bowe, B. & Al-Aly, Z. Long-term cardiovascular outcomes of COVID19. Nature Medicine 2022 28:3 28, 583–590 (2022).
26.
Wang, W., Wang, C. Y., Wang, S. I. & Wei, J. C. C. Long-term cardiovascular outcomes
in COVID-19 survivors among non-vaccinated population: A retrospective cohort
study from the TriNetX US collaborative networks. EClinicalMedicine 53, (2022).
27.
Raisi-Estabragh, Z. et al. Cardiovascular disease and mortality sequelae of COVID-19
in the UK Biobank. Heart 0, heartjnl-2022-321492 (2022).
28.
Mahase, E. Covid-19: Pandemic disruption linked to 30 000 excess heart disease
deaths, charity reports. BMJ 379, o2659 (2022).
29.
Yeo, Y. H. et al. Excess risk for acute myocardial infarction mortality during the
COVID-19 pandemic. J Med Virol (2022) doi:10.1002/JMV.28187.
14
Faust, J. S. & del Rio, C. Assessment of Deaths From COVID-19 and From Seasonal
Influenza. JAMA Intern Med 180, 1045–1046 (2020).
16.
World Health Organization. Estimating mortality from COVID-19. Scientific Brief.
https://www.who.int/news-room/commentaries/detail/estimating-mortality-fromcovid-19 (2020).
17.
Baker, M. G. & Wilson, N. The covid-19 elimination debate needs correct data. BMJ
371, (2020).
18.
Leung, N. H. L., Xu, C., Ip, D. K. M. & Cowling, B. J. The fraction of influenza virus
infections that are asymptomatic: a systematic review and meta-analysis. Epidemiology
26, 862 (2015).
19.
Askani, E. et al. Computed Tomographic Imaging Features of COVID-19 Pneumonia
Caused by the Delta (B.1.617.2) and Omicron (B.1.1.529) Variant in a German
Nested Cohort Pilot Study Group. Tomography 2022, Vol. 8, Pages 2435-2449 8,
2435–2449 (2022).
20.
Yoon, S. H., Lee, J. H. & Kim, B.-N. Chest CT Findings in Hospitalized Patients with
SARS-CoV-2:
Delta
versus
Omicron
Variants.
https://doi.org/10.1148/radiol.220676 (2022) doi:10.1148/RADIOL.220676.
21.
Falsey, A. R. & Walsh, E. E. Viral pneumonia in older adults. Clinical Infectious
Diseases 42, 518–524 (2006).
22.
Bhattacharyya, R. P. & Hanage, W. P. Challenges in Inferring Intrinsic Severity of the
SARS-CoV-2 Omicron Variant. New England Journal of Medicine 386, e14 (2022).
23.
Guo, T. et al. Cardiovascular Implications of Fatal Outcomes of Patients with
Coronavirus Disease 2019 (COVID-19). JAMA Cardiol 5, 811–818 (2020).
24.
Zheng, Y.-Y., Ma, Y.-T., Zhang, J.-Y. & Xie, X. COVID-19 and the cardiovascular
system. Nat Rev Cardiol doi:10.1038/s41569-020-0360-5.
25.
Xie, Y., Xu, E., Bowe, B. & Al-Aly, Z. Long-term cardiovascular outcomes of COVID19. Nature Medicine 2022 28:3 28, 583–590 (2022).
26.
Wang, W., Wang, C. Y., Wang, S. I. & Wei, J. C. C. Long-term cardiovascular outcomes
in COVID-19 survivors among non-vaccinated population: A retrospective cohort
study from the TriNetX US collaborative networks. EClinicalMedicine 53, (2022).
27.
Raisi-Estabragh, Z. et al. Cardiovascular disease and mortality sequelae of COVID-19
in the UK Biobank. Heart 0, heartjnl-2022-321492 (2022).
28.
Mahase, E. Covid-19: Pandemic disruption linked to 30 000 excess heart disease
deaths, charity reports. BMJ 379, o2659 (2022).
29.
Yeo, Y. H. et al. Excess risk for acute myocardial infarction mortality during the
COVID-19 pandemic. J Med Virol (2022) doi:10.1002/JMV.28187.
14